Grant Baldwin
PhD, MPH

Dr. Grant Baldwin is the Director of the Division of Overdose Prevention at CDC National Center for Injury Prevention and Control. In this role, he is responsible for monitoring trends in the opioid epidemic and other emerging drug threats as well identifying and scaling up prevention activities to address the evolving drug crisis. This includes supporting local drug-free community coalitions too. Prior to this appointment in October 2019, Dr. Baldwin served as the Director of the Division of Unintentional Injury Prevention for 11 years where he helped raise the profile of motor vehicle injury prevention, advanced work in older adult fall prevention and traumatic brain injury prevention, and established the initial CDC response to the prescription opioid overdose epidemic. As the scope, scale, and complexity of America’s drug overdose epidemic changed, the Division of Overdose Prevention was created to serve as a necessary and essential focal point to CDC’s more expansive and diversified work in the area. Dr. Baldwin has been at CDC for over 27 years. Dr. Baldwin received his PhD in Health Behavior and Health Education at the University of Michigan. He received a MPH in Behavioral Sciences and Health Education from Emory University, and is currently an affiliated professor at Emory University. Dr. Baldwin has given keynote addresses or provided remarks at over 150 state, national and international conferences and meetings, has authored or coauthored more than 80 peer-reviewed publications, and has received awards of excellence for his leadership and teaching.

Sessions

Register

Better Without It: Designing an Impactful Prevention Message for Generation Z

Monday, April 01, 2024
1:00 PM - 2:15 PM

Teaching Adolescent Brain Development and Mental Wellbeing Strategies to Youth in the Prevention of Substance Use and Self Harm

Monday, April 01, 2024
2:30 PM - 3:45 PM

Federal Law Enforcement and Public Health Collaboration on the Opioid Rapid Response Program: A Replicable Program to Mitigate Risks to Patients Who Lose Access to Prescribed Opioid Medication

Tuesday, April 02, 2024
8:00 AM - 9:15 AM